Press Releases
Diagnostic tool for Coronavirus being developed by University of Warwick makes significant step forward
Scientists at the University of Warwick have demonstrated that a potential diagnostic tool for detecting COVID-19 using sugars will work with a virus rather than just its proteins, a significant step in making it a viable test in future.
Novel magnetic stirrer speaks to lab equipment
A small device, called “Smart Stirrer”, performed a function of a conventional laboratory stir bar, has an integrated microprocessor and various sensors capable of wireless and autonomous report the conversion of properties of a solution. Results are sent to a computer over Bluetooth, and any changes notify the user wirelessly.
National award for project to bring chemistry to life in schools
A project co-developed by a University of Warwick researcher that uses real-world research to bring chemistry to life for school students has been recognised with a national award from the Royal Society of Chemistry.
New diagnostic tool for rapid detection of Coronavirus being developed by University of Warwick and Partners
Coronavirus diagnostics currently require centralised facilities and collection/distribution of swabs and results are ‘next day’. A new diagnostic tool being developed by the University of Warwick and its partner Iceni Diagnostics may allow on-the-spot detection of Coronavirus infection, without out facilities using a simple disposal device.
500 scientists, including the University of Warwick, to map COVID-19 effects and treatments in patients’ blood
A new coalition of more than 500 scientists from around the world, including the University of Warwick, has been created to share data on COVID-19 gleaned from the use of mass spectrometry techniques which examine people’s blood and other biomarkers.
Midlands Medictech company Medherant in partnership to develop multiple new products with tech developed at University of Warwick
Midlands Medictech company Medherant has just this month (May 2020) signed a partnership agreement with Cambridge based Cycle Pharmaceuticals to develop multiple new products using Medherant technology developed by University of Warwick chemistry researchers. Coventry based Medherant’s TEPI Patch® Technology uses transdermal delivery technology (a patch that can simply be applied to the skin) and medicines for rare diseases combine to deliver significant quality-of-life benefits for patients.